Mitochondrial oxidative stress is a key pathologic factor in neurodegenerative diseases, including Alzheimeŕs disease. Abnormal generation of reactive oxygen species (ROS), resulting from mitochondrial dysfunction, can lead to neuronal cell death. Ceria (CeO2) nanoparticles are known to function as strong and recyclable ROS scavengers by shuttling between Ce3+ and Ce4+ oxidation states. Consequently, targeting ceria nanoparticles selectively to mitochondria might be a promising therapeutic approach for neurodegenerative diseases. Here, we report the design and synthesis of triphenylphosphonium-conjugated ceria nanoparticles that localize to mitochondria and suppress neuronal death in a 5XFAD transgenic Alzheimeŕs disease mouse model. The triphenylphosphonium-conjugated ceria nanoparticles mitigate reactive gliosis and morphological mitochondria damage observed in these mice. Altogether, our data indicate that the triphenylphosphonium-conjugated ceria nanoparticles are a potential therapeutic candidate for mitochondrial oxidative stress in Alzheimeŕs disease.
CITATION STYLE
Kwon, H. J., Cha, M. Y., Kim, D., Kim, D. K., Soh, M., Shin, K., … Mook-Jung, I. (2016). Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimeŕs Disease. ACS Nano, 10(2), 2860–2870. https://doi.org/10.1021/acsnano.5b08045
Mendeley helps you to discover research relevant for your work.